In the Diabetes Prevention Program, the TT genotype of TCF7L2 rs7903146 showed a tendency towards being more strongly associated with type 2 diabetes in the placebo group compared with the intervention group but the results did not reach statistical significance [11]. This evidence concerns the gene TCF7L2 and type 2 diabetes mellitus.